US 12403196
Ras inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 12403196 (Ras inhibitors) held by Revolution Medicines, Inc. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Revolution Medicines, Inc.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00